<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!-- saved from url=(0052)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/ -->
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="bmcresnotes"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3571969/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Case report of exercise and statin-fibrate combination therapy-caused myopathy in a patient with metabolic syndrome: contradictions between the two main therapeutic pathways</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="./PMC3571969_files/jig.min.css"><script type="text/javascript" src="./PMC3571969_files/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="BMC Research Notes"><meta name="citation_title" content="Case report of exercise and statin-fibrate combination therapy-caused myopathy in a patient with metabolic syndrome: contradictions between the two main therapeutic pathways"><meta name="citation_authors" content="Andrea László, László Kalabay, János Nemcsik"><meta name="citation_date" content="2013"><meta name="citation_volume" content="6"><meta name="citation_firstpage" content="52"><meta name="citation_doi" content="10.1186/1756-0500-6-52"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3571969/?report=abstract"><meta name="citation_pmid" content="23388500"><meta name="DC.Title" content="Case report of exercise and statin-fibrate combination therapy-caused myopathy in a patient with metabolic syndrome: contradictions between the two main therapeutic pathways"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="BioMed Central"><meta name="DC.Contributor" content="Andrea László"><meta name="DC.Contributor" content="László Kalabay"><meta name="DC.Contributor" content="János Nemcsik"><meta name="DC.Date" content="2013"><meta name="DC.Identifier" content="10.1186/1756-0500-6-52"><meta name="DC.Language" content="en"><meta property="og:title" content="Case report of exercise and statin-fibrate combination therapy-caused myopathy in a patient with metabolic syndrome: contradictions between the two main therapeutic pathways"><meta property="og:type" content="article"><meta property="og:description" content="Lifestyle modifications including exercise are beneficial and fundamentally part of the therapy of metabolic syndrome, although in most of the cases medical interventions are also required to reach the target values in the laboratory parameters. Statin ..."><meta property="og:url" content="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="http://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="./PMC3571969_files/pmc.min.css" type="text/css"><link rel="stylesheet" href="./PMC3571969_files/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="./PMC3571969_files/common.min.js">//</script><script type="text/javascript" src="./PMC3571969_files/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:&#39;/pmc/utils/ctxp/&#39;"><script type="text/javascript" src="./PMC3571969_files/jquery.citationexporter.js">//</script><link rel="stylesheet" href="./PMC3571969_files/citationexporter.css" type="text/css"><script type="text/javascript" src="./PMC3571969_files/MathJax.js"></script><script type="text/javascript" src="./PMC3571969_files/large-obj-scrollbars.min.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-bmcresnotes.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><link rel="alternate" type="application/epub+zip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/epub/"><link rel="alternate" type="application/pdf" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/pdf/1756-0500-6-52.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="http://www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="F4FC415C76C2A58100000000002B72CA"><link type="text/css" rel="stylesheet" href="./PMC3571969_files/3855312.css"><link type="text/css" rel="stylesheet" href="./PMC3571969_files/3929378.css" media="print"><style type="text/css" media="print">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('http://www.ncbi.nlm.nih.gov/stat?jsevent=print&ncbi_app=pmc&ncbi_db=pmc&ncbi_pcid=%2Farticles%2FPMC3571969%2F&ncbi_pdid=article&ncbi_phid=F4FC415C76C2A58100000000002B72CA'); }</style><style type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-jig-5"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="http://www.ncbi.nlm.nih.gov/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="./PMC3571969_files/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="http://www.ncbi.nlm.nih.gov/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="http://www.ncbi.nlm.nih.gov/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3571969%2F" id="sign_in">Sign in to NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/signout/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3571969%2F" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="http://www.ncbi.nlm.nih.gov/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="http://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="http://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="http://www.ncbi.nlm.nih.gov/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbook">ToolKitBook</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" config="dictionary:&#39;pmc-search-autocomplete&#39;,disableUrl:&#39;NcbiSearchBarAutoComplCtrl&#39;" autocomplete="off" data-sbconfig="ds:&#39;no&#39;,pjs:&#39;no&#39;,afs:&#39;yes&#39;" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" style="visibility: hidden;"><img src="./PMC3571969_files/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/limits/">Limits</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="http://www.ncbi.nlm.nih.gov/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="http://www.ncbi.nlm.nih.gov/pmc/journals/" class="navlink">Journal List</a></li><li class="archive-page"><a class="navlink" href="http://www.ncbi.nlm.nih.gov/pmc/journals/634/">BMC Res Notes</a></li><li class="issue-page"><a class="navlink" href="http://www.ncbi.nlm.nih.gov/pmc/issues/218000/">v.6; 2013</a></li><li class="accid">PMC3571969</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="./PMC3571969_files/logo-bmcresnotes.png" alt="Logo of bmcresnotes" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,162,75" alt="BioMed Central" title="BioMed Central" href="http://www.biomedcentral.com/" ref="reftype=publisher&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="0,0,99,74" alt="biomed central web site" title="biomed central web site" href="http://www.biomedcentral.com/" ref="reftype=publisher&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="247,59,296,75" alt="search" title="search" href="http://www.biomedcentral.com/search" ref="reftype=publisher&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="301,59,405,75" alt="submit a manuscript" title="submit a manuscript" href="http://www.biomedcentral.com/manuscript" ref="reftype=publisher&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="415,59,458,75" alt="register" title="register" href="http://www.biomedcentral.com/register" ref="reftype=publisher&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="185,59,244,75" alt="this article" title="this article" href="http://dx.doi.org/10.1186/1756-0500-6-52" ref="reftype=publisher&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="0,0,480,75" alt="BMC Research Notes" title="BMC Research Notes" href="http://www.biomedcentral.com/" ref="reftype=publisher&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="0,0,480,74" alt="journal front page" title="journal front page" href="http://www.biomedcentral.com/bmcresnotes" ref="reftype=publisher&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [&#39;h2&#39;], headingExclude: &#39;:hidden&#39;" id="ui-jig-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><div><span class="cit">BMC Res Notes. 2013; 6: 52. </span></div><div><span class="fm-vol-iss-date">Published online 2013 Feb 6. </span>  <span class="doi">doi:&nbsp; <a href="http://dx.doi.org/10.1186%2F1756-0500-6-52" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1186/1756-0500-6-52</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3571969</span></div></div></div></div></div><h1 class="content-title">Case report of exercise and statin-fibrate combination therapy-caused myopathy in a patient with metabolic syndrome: contradictions between the two main therapeutic pathways</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=L%26%23x000e1%3Bszl%26%23x000f3%3B%20A%5Bauth%5D">Andrea László</a>,<sup>1</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kalabay%20L%5Bauth%5D">László Kalabay</a>,<sup><img src="./PMC3571969_files/corrauth.gif" alt="corresponding author"></sup><sup>1</sup> and  <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nemcsik%20J%5Bauth%5D">János Nemcsik</a><sup>1</sup></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="id1096603_ai" style="display:none"><div class="fm-affl" lang="en"><sup>1</sup>Department of Family Medicine, Semmelweis University, Kútvölgyi str. 4, Budapest, 1125, Hungary</div><div><sup><img src="./PMC3571969_files/corrauth.gif" alt="corresponding author"></sup>Corresponding author.</div><div><span class="contrib-email" id="A1">Andrea László: <a href="mailto:dev@null" data-email="moc.liamg@aerdnaolzsal" class="oemail">moc.liamg@aerdnaolzsal</a>; </span> <span class="contrib-email" id="A2">László Kalabay: <a href="mailto:dev@null" data-email="uh.etos.tuk@zsalak" class="oemail">uh.etos.tuk@zsalak</a>; </span> <span class="contrib-email" id="A3">János Nemcsik: <a href="mailto:dev@null" data-email="moc.liamg@kiscmen.sonaj" class="oemail">moc.liamg@kiscmen.sonaj</a></span> </div></div><div class="togglers"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" class="pmctoggle" rid="id1096603_ai">Author information <span>►</span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" class="pmctoggle" rid="id1096603_an">Article notes <span>►</span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" class="pmctoggle" rid="id1096603_cpl">Copyright and License information <span>►</span></a></div><div class="fm-article-notes fm-panel hide half_rhythm" id="id1096603_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2012 Dec 6; Accepted 2013 Jan 29.</div></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="id1096603_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright</a>  ©2013 László et al.; licensee BioMed Central Ltd.</div><div class="fm-copyright half_rhythm">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/2.0" ref="reftype=extlink&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="pmc_ext">http://creativecommons.org/licenses/by/2.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div></div><div class="sec"></div><div id="__abstractid1154731" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-7"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true" id="ui-jig-8">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__abstractid1154731title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3>Background</h3><p id="__p1" class="p p-first-last">Lifestyle modifications including exercise are beneficial and fundamentally part of the therapy of metabolic syndrome, although in most of the cases medical interventions are also required to reach the target values in the laboratory parameters. Statin and fibrate combination therapy is considered to be safe and effective in dyslipidaemia and metabolic syndrome. However, increased physical activity can enhance the statin and fibrate-associated myopathy. Myositis and the rare but life-threatening rhabdomyolysis are causing a conflict between exercise and statin-fibrate therapy, which is yet to be resolved.</p></div><div id="__sec2" class="sec"><h3>Case presentation</h3><p id="__p2" class="p p-first-last">We present a case of a 43-year-old Caucasian man with metabolic syndrome who had the side-effect of exercise and drug-associated myositis. The patient had only transient moderate complaints and rhabdomyolysis could be avoided with the one-month creatine kinase control, a test which is not recommended routinely by the new guidelines.</p></div><div id="__sec3" class="sec sec-last"><h3>Conclusions</h3><p id="__p3" class="p p-first-last">We would like to turn the spotlight on the possible complications of statin-fibrate therapy and exercise, when strict follow-up is recommended. In this condition high number of patients can be affected and the responsibility of general practitioners is accentuated.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Metabolic syndrome, Exercise, Statin-fibrate combination therapy, Myopathy, Creatine kinase</span></div></div><div id="__sec4" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-9"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-10">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec4title">Background</h2><p id="__p4" class="p p-first">Cardiovascular disease is the leading cause of death in developed countries. In adults besides body mass index above 30 kg/m<sup>2</sup> or elevated waist circumference, the clustered presence of 2 or more cardiovascular risk factors from among high triglyceride and fasting blood glucose levels, low high-density lipoprotein cholesterol (HDL-C), raised blood pressure and the presence of treated hypertension or type 2 diabetes has been designated the “metabolic syndrome” (MetS) [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162569" role="button" aria-expanded="false" aria-haspopup="true">1</a>]. These components are the principal risk factors in the development of atherosclerosis and cardiovascular disease. Related to this high risk status, the treatment of patients with MetS is an important task of the basic healthcare.</p><p id="__p5">There is substantial evidence that regular exercise has beneficial effects in physical and mental health and contributes to the primary and secondary prevention of cardiovascular and several chronic diseases, like breast and colon cancer or diabetes [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162578" role="button" aria-expanded="false" aria-haspopup="true">2</a>]. Exercise improves a variety of lipid and lipoprotein variables [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162585" role="button" aria-expanded="false" aria-haspopup="true">3</a>] and is a fundamental part of the therapy of MetS.</p><p id="__p6">The alternative of the lifestyle modifications is the use of tablets. For the correction of lipid disorders in MetS, recommendations, like the recent European guideline (European Society of Cardiology and the European Atherosclerosis Society (ESC/EAS 2011) [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827008" role="button" aria-expanded="false" aria-haspopup="true">4</a>]) aims a certain level of serum lipids. Not only statin or fibrate treatment, but their combination may be also required to achieve target lipid levels (cholesterol, LDL-C, triglycerides, HDL-C), which appears to confer additional cardiovascular risk – compared with LDL-C alone [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162566" role="button" aria-expanded="false" aria-haspopup="true">5</a>]. The combination therapy is especially recommended in MetS and diabetes with the administration of fenofibrate besides the statins [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827014" role="button" aria-expanded="false" aria-haspopup="true">4</a>].</p><p id="__p7">Although the use of statins considered to be safe, some studies suggest that the frequency of statin myopathy is between 9% and 20% [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162579" role="button" aria-expanded="false" aria-haspopup="true">6</a>-<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162587" role="button" aria-expanded="false" aria-haspopup="true">8</a>]. If muscle symptoms are accompanied by the elevation of creatine kinase (CK) levels, the condition is known as myositis [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162562" role="button" aria-expanded="false" aria-haspopup="true">9</a>-<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162583" role="button" aria-expanded="false" aria-haspopup="true">11</a>]. Rhabdomyolysis is the most serious side-effect of the statin therapy, where renal insufficiency is present, as well. However, in some studies this side effect was found to be rare (affecting 0,1% of statin users) [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827007" role="button" aria-expanded="false" aria-haspopup="true">12</a>-<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162572" role="button" aria-expanded="false" aria-haspopup="true">15</a>], and moreover no cases of drug-related rhabdomyolysis were reported in some follow-up studies [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162570" role="button" aria-expanded="false" aria-haspopup="true">16</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162568" role="button" aria-expanded="false" aria-haspopup="true">17</a>]. Statins combined with fibrate also increase the incidence of statin-induced myopathies [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162582" role="button" aria-expanded="false" aria-haspopup="true">11</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162561" role="button" aria-expanded="false" aria-haspopup="true">18</a>-<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162571" role="button" aria-expanded="false" aria-haspopup="true">20</a>], suggested a 5.5-fold greater elevation compared with statin use alone [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827016" role="button" aria-expanded="false" aria-haspopup="true">21</a>].</p><p id="__p8">In addition, physical exercise can also influence the occurrence of myopathy in patients using statins and fibrates. Muscle complaints may affect 25% of the statin users who exercise [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162586" role="button" aria-expanded="false" aria-haspopup="true">22</a>], and the prevalence of this phenomenon is 75% among athletes who take the drug [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162573" role="button" aria-expanded="false" aria-haspopup="true">23</a>].</p><p id="__p9">Although the new ESC guideline on dyslipidaemias is expansively engaged in lifestyle modifications, it does not focus on the problem of the elevated risk of myopathy during statin-fibrate therapy and exercise [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827013" role="button" aria-expanded="false" aria-haspopup="true">4</a>]. This condition is not mentioned as a recommended reason for periodic CK control [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827005" role="button" aria-expanded="false" aria-haspopup="true">4</a>].</p><p id="__p10" class="p p-last">In our case report we present a patient with MetS who took statin and fibrate therapy and started parallel exercise leading to myositis with moderate symptoms but excessive CK elevation.</p></div><div id="__sec5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-11"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-12">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec5title">Case presentation</h2><p id="__p11" class="p p-first">On routine laboratory examination dyslipidaemia was found in a 43-year-old man without symptoms, who presented in our general practitioner praxis in October 2011. The patient was obese (body mass index 31.7 kg/m<sup>2</sup>, waist circumference 104 cm), with the history of 25 pack-year smoking and 2 units (20 ml) of alcohol intake per week. His hypertension started 10 years ago and was controlled with 2.5 mg nebivolol per day. He was a blue-collar worker in a storehouse, and sometimes did manual work (not every day and not exhausting).</p><p id="__p12">His values were: total cholesterol 277.7 mg/dL, triglycerides 448.2 mg/dL, HDL-C 36.7 mg/dl, fasting plasma glucose level was 5.68 mmol/L. LDL-C could not have been evaluated, because the elevated serum triglyceride level disturbed the measurement. Based on data above, the patient fulfilled the requirements of MetS (central obesity, raised serum triglycerides, reduced HDL-C, treated hypertension and upper range of normal fasting glucose level were present). Other parameters, like creatine kinase (CK), aspartate transaminase (AST), alanine transaminase (ALT) and gamma glutamyl transpeptidase (GGT) were in the normal range (117 U/l, 26 U/l, 23 U/l and 36 U/l, respectively). Renal function (blood urea nitrogen: 7.6 mmol/l, serum creatinine: 97 μmol/L, glomerular filtration rate: &gt;60 ml/min) was also normal. Past medical history included laparoscopic cholecystectomy in his 30s. From family history hypertension, hypercholesterinaemia and obesity of both parents must be mentioned. None of them had any side effect for drug administration (both of them took statins).</p><p id="__p13">After informing the patient about his elevated cardiovascular risk, he ensured us to cooperate regarding taking the prescribed medications (except for aspirin, because of bad family experience). About lifestyle modifications he did not see possibilities for exercise because of his exhausting job. On the other hand, about diet he said, that he tried to decrease the calorie intake long ago, but because of his manual work he often felt hungry and required extra meals. He promised to keep this kind of diet in the future as well, which apparently was not enough. Due to the high triglycerides and lack of lifestyle modification possibilities, 160 mg fenofibrate per day was applied. The patient was also informed about the possible side-effects of the lipid-lowering therapy. Because of smoking, varenicline therapy was prescribed as well, as the patient previously failed to give up smoking with lifestyle modifications and the use of nicotine patch.</p><p id="__p14">The patient came for one-month control without any symptoms, and mentioned that he had begun taking varenicline only one week earlier. Laboratory parameters revealed the efficacy of the therapy. Serum triglycerides were reduced, but remained above the target level (349 mg/dL), CK was in the normal range (121 U/l), but cholesterol showed further increase (310.5 mg/dL). Taking the lipid levels and the high cardiovascular risk of the patient due to MetS into consideration, 20 mg atorvastatin per day was added to the therapy. Similarly, a control laboratory test was set one month later.</p><p id="__p15">The patient was also asymptomatic at the second control. This time both the values of triglycerides and cholesterol showed improvement, 154.1 and 249.8 mg/dL, respectively. However, in the CK level a more than 150-fold elevation was observed (18979 U/l). Kept on asking the possible symptoms, the patient told us that he had changed his mind about exercise and one week ago he bought body-building equipment. After he worked out with all kind of dumb-bells, he had moderate pain and stiff feeling everywhere in his chest and in both arms and legs and dark urine was observed parallel. The pain lasted for three days, than the symptoms disappeared. At the time of the control he had no muscle complaints.</p><p id="__p16">He had stopped taking varenicline after 2 weeks, and had taken the three types of medicines together (statin, fibrate and varenicline) only one week long. He did not smoke since then. The irregular moderate alcohol consumption was continued during taking the prescribed medications, as well.</p><p id="__p17">The findings of the physical examinations were normal. The electrocardiography did not show any relevant pathological abnormalities. Based on these data, the patient was sent to the emergency care unit of the territorial hospital with the diagnosis of rhabdomyolysis. He was admitted to the Department of Cardiology.</p><p id="__p18">In the hospital on the day of admission in blood test results ALT (131.5 U/l) and AST (247.7 U/l) were elevated, while GGT remained in the normal range (38 U/l). The lactate dehydrogenase (LDH) level was also increased, 463 U/l. Statin and fibrate medications were stopped, and altogether 2 litres of Salsol infusion was administered. On the next days CK showed decreasing tendency (5134, 1823 U/l), and reduction was observed in one of the levels of liver transaminases (AST: 131.3; ALT: 95.5 U/l), and in LDH (386 U/l). Serum cholesterol level remained elevated (257.2 mg/dL), triglycerides reached the normal range (151.5 mg/dL). Kidney function parameters did not show any abnormalities, and the thyroid function test was also normal (thyroid-stimulating hormone 1.42 μU/ml). As the patient remained asymptomatic, and the laboratory controls indicated improvement, he was discharged following 2 days of hospitalization. Strict alcohol abstinence, 180 grams/day carbohydrate diet with low fat and salt intake were recommended at emission, completed with fish oil capsules and dietary sources of omega-3 fatty acids. Future contraindication of statin-fibrate combination therapy was stated, and laboratory control was advised in two days.</p><p id="__p19">The control showed further improvement in the levels of transaminases, CK and LDH, but they were still moderately elevated (AST 58.8 U/l, ALT 72.1 U/l, CK 526 U/l, LDH 417 U/l). One month later the laboratory control was repeated in our praxis: CK and transaminases were normal, dyslipidaemia was reduced (total cholesterol and triglycerides levels were 238.3 and 216.1 mg/dL, respectively). Since that time the patient has been asymptomatic, keeps diet, exercises regularly (with no marked CK elevation), takes 1 gram omega-3 fatty acid per day, and thanks to the varenicline therapy he does not smoke.</p><p id="__p20">The diagnosis of drug-induced myositis was reported to the Hungarian National Institute of Pharmacy.</p><p id="__p21">According to the recommendation of ESC/EASC guideline for the management of dyslipidaemias, it is always appropriate to advise patients to engage in regular physical exercise of moderate intensity [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162580" role="button" aria-expanded="false" aria-haspopup="true">24</a>]. Lifestyle modification is recommended as the first step treating MetS, as well [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827012" role="button" aria-expanded="false" aria-haspopup="true">4</a>]. In fact, physical activity is one of the most cost-effective ways to prevent cardiovascular diseases.</p><p id="__p22">However, lifestyle interventions considered being difficult to be maintained, and drugs are frequently prescribed as it is influenced by pharmaceutical industry pressure, as well [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162559" role="button" aria-expanded="false" aria-haspopup="true">25</a>]. Moreover, statin therapy has been suggested to be a fundamental tool of the prevention of coronary artery disease [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162584" role="button" aria-expanded="false" aria-haspopup="true">26</a>]. There is a growing concern that this total focus on statin use may distract attention from simple lifestyle changes and also interfere with exercise [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162560" role="button" aria-expanded="false" aria-haspopup="true">22</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162581" role="button" aria-expanded="false" aria-haspopup="true">27</a>].</p><p id="__p23">In our patient fibrate and later statin-fibrate medications were initiated because of the limited lifestyle changing possibilities. However, the patient changed his mind and started exercise which led to severe myositis but only moderate symptoms.</p><p id="__p24">Although the patient had been already on combination therapy when the myositis started but the main cause of it was probably the atrovastatin as compared with gemfibrozil, fenofibrate were found to be less prone to make complications when used together with statins [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162564" role="button" aria-expanded="false" aria-haspopup="true">28</a>]. However, the pathophysiological role of fenofibrate or the exaggerating effect in the extent of CK elevation cannot be excluded.</p><p id="__p25">Our case report shows the emerging problem of parallel application of exercise and statin-fibrate therapy. Although this problem is not new but still some questions are opened. It is not clear, what kind of exercise is safe and can be recommended besides statin-fibrate use. Especially prolonged exercise, like weight bearing and those which require eccentric muscular contractions (for example downhill treadmill walking) seem to exacerbate muscle injury [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162577" role="button" aria-expanded="false" aria-haspopup="true">29</a>-<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162575" role="button" aria-expanded="false" aria-haspopup="true">32</a>]. So far no study has addressed the risk of exercise during statin and fibrate use or the possibly recommended type of gymnastics which are safe, but still beneficial in this condition.</p><p id="__p26">Amongst other possible pathophysiological factors the moderate alcohol consumption of our patient probably did not influence the exercise-induced statin-myopathy as in low amounts (12.7-38.1 ml of ethanol per day in men) it was not found to be harmful [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162567" role="button" aria-expanded="false" aria-haspopup="true">24</a>].</p><p id="__p27">Another question arises whether the statin-fibrate therapy-induced rhabdomyolysis could be connected to varenicline intake. The theoretical background of this interaction is based on the observation of Obrach et al., who found two metabolites in human excreta of varenicline: one of them is the N-carbamoylglucuronide, catalyzed by the UDP-glucuronosyltransferase-2B7 (UGT2B7) [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162574" role="button" aria-expanded="false" aria-haspopup="true">33</a>]. Fenofibrate is also glucuronidated by this enzyme [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827011" role="button" aria-expanded="false" aria-haspopup="true">34</a>]. Thus a varenicline-fenofibrate interaction is theoretically possible. In our case, 3 weeks after starting the fibrate therapy the patient began to take varenicline, and one week later atorvastatin. He took altogether a 2-week dose of varenicline where in the second week he took fenofibrate and atorvastatin, as well. The symptoms started two weeks after the stop of varenicline, so it probably had no role in the side effect.</p><p id="__p28">Statin-fibrate combination should be prescribed with caution to patients who also receive other drugs that are metabolized through CYP 450. [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827010" role="button" aria-expanded="false" aria-haspopup="true">4</a>] Although the aromatic hydroxylation of nebivolol takes place in CYP 2D6 [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B35" rid="B35" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">35</a>], a single nucleotid polymorphism of this type of cytochrome enzyme (the presence of CYP 2D6*4 allele) was also found to be associated with statin-induced muscle effects [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_298162565" role="button" aria-expanded="false" aria-haspopup="true">36</a>]. Although interaction between statins and nebivolol has not been published yet, nebivolol might have influenced the development of rhabdomyolysis in our patient. Unfortunately we did not have the opportunity to check the presence of this CYP 2D6*4 phenotype in our patient.</p><p id="__p29">According to the guidelines, although pre-treatment CK level is required to be measured, routine monitoring of the enzyme without symptoms of myopathy/rhabdomyolysis, or risk factors is not necessary [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827006" role="button" aria-expanded="false" aria-haspopup="true">4</a>]. Furthermore, recent studies have suggested, that routine examinations for side effects are not cost-effective [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827009" role="button" aria-expanded="false" aria-haspopup="true">10</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_324827015" role="button" aria-expanded="false" aria-haspopup="true">37</a>]. However, in our patient, who had no symptoms at the regular visits, the routine laboratory CK control indicated the severe myopathy and with the urgent intervention the development of acute renal failure and other severe complications could be prevented. Based on our case, the control of CK should also be added to lipid function control 4–6 weeks after the initiation of statin-fibrate combined therapy especially in those patients who do exercise parallel.</p><p id="__p30" class="p p-last">Finally, we must mention some emerging critical aspects of our medical attendance. With more impressions, the patient might have been convinced about the necessity of lifestyle modifications before the drug administrations. Unfortunately the patients' attitude and the insufficiency of time which can be expended for each patient in the office of a general practitioner sometimes limit our success. Secondly, fenofibrate was administered first instead of atrovastatin. This choice also can be debated, but we have chosen fibrate because of the more, than 3-fold higher triglyceride and the moderately elevated total cholesterol at the beginning. Third, unfortunately at the first blood test LDL-cholesterol could not have been evaluated because of the disturbing effect of raised triglyceride. Later at the control blood tests only total cholesterol was measured. LDL-cholesterol is an essential parameter of cardiovascular risk stratification and must be the part of the general laboratory protocol.</p></div><div id="__sec6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-13"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-14">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec6title">Conclusions</h2><p id="__p31" class="p p-first-last">In conclusion, although fenofibrate and statin combination therapy is supposed to be safe, myopathy, myositis and rhabdomyolysis still can develop. Exercise, as a part of lifestyle modifications can increase the risk of muscle side effects besides drug therapy providing a conflict between the two main therapeutic pathways of MetS. Further studies are required to define the types of exercise which are safe together with lipid lowering medications. The incidental interaction of nebivolol with statins or fibrates is also need to be clarified in the future. Moreover, also by asymptomatic patients the one-month CK control is important when exercise is present besides statin-fibrate therapy. In our case this test prevented the development of further serious complications.</p></div><div id="__sec7" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-15"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-16">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec7title">Consent</h2><p id="__p32" class="p p-first-last">Written informed consent was obtained from the patient for publication of the Case report. A copy of a written consent is available for review by the Series Editor of this journal.</p></div><div id="__sec8" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-17"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-18">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec8title">Abbreviations</h2><p id="__p33" class="p p-first-last">MetS: Metabolic syndrome; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; ESC/EAS: European Society of Cardiology and the European Atherosclerosis Society; CK: Creatine kinase; AST: Aspartate transaminase; ALT: Alanine transaminases; GGT: Gamma glutamyl transpeptidase; LDH: Lactate dehydrogenase; CYP: Cytochrome P enzyme; GFR: Glomerular filtration rate.</p></div><div id="__sec9" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-19"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-20">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec9title">Competing interests</h2><p id="__p34" class="p p-first-last">The authors declare that they have no competing interests.</p></div><div id="__sec10" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-21"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-22">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec10title">Authors’ contributions</h2><p id="__p35" class="p p-first-last">AL has collected the required data of the patient and has written the manuscript. LK revised the manuscript critically for important intellectual content. JN treated and followed the patient and revised the manuscript. All authors read and approved the final manuscript.</p></div><div id="__sec11" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-23"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-24">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec11title">Acknowledgements</h2><!--/article/back/sec/--><p id="__p36" class="p p-first-last">Authors acknowledge the contribution of Lászlóné Hárshegyi, who helped in the care of the patient and in the data acquisition. No authors had any source of funding.</p></div><div id="__ref-listid1131749" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-25"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-26">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ref-listid1131749title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="B1"><span class="mixed-citation">Alberti KG, Zimmer P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. <span><span class="ref-journal">Lancet. </span>2005;<span class="ref-vol">366</span>(9491):1059–62. doi: 10.1016/S0140-6736(05)67402-8.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16182882" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2FS0140-6736(05)67402-8" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B2"><span class="mixed-citation">Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. <span><span class="ref-journal">Cmaj. </span>2006;<span class="ref-vol">174</span>(6):801–809.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1402378/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16534088" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B3"><span class="mixed-citation">Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD. et al. Effects of the amount and intensity of exercise on plasma lipoproteins. <span><span class="ref-journal">N Engl J Med. </span>2002;<span class="ref-vol">347</span>(19):1483–1492. doi: 10.1056/NEJMoa020194.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12421890" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1056%2FNEJMoa020194" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B4"><span class="mixed-citation">Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P. et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) <span><span class="ref-journal">Eur Hear J. </span>2011;<span class="ref-vol">32</span>(14):1769–1818.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/21712404" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B5"><span class="mixed-citation">Stanek EJ, Sarawate C, Willey VJ, Charland SL, Cziraky MJ. Risk of cardiovascular events in patients at optimal values for combined lipid parameters. <span><span class="ref-journal">Curr Med Res Opin. </span>2007;<span class="ref-vol">23</span>(3):553–563. doi: 10.1185/030079906X167660.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17357251" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1185%2F030079906X167660" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B6"><span class="mixed-citation">de Sauvage Nolting PR, Buirma RJ, Hutten BA, Kastelein JJ. Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]) <span><span class="ref-journal">Am J Cardiol. </span>2002;<span class="ref-vol">90</span>(2):181–184. doi: 10.1016/S0002-9149(02)02449-9.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12106856" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2FS0002-9149(02)02449-9" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B7"><span class="mixed-citation">Franc S, Dejager S, Bruckert E, Chauvenet M, Giral P, Turpin G. A comprehensive description of muscle symptoms associated with lipid-lowering drugs. <span><span class="ref-journal">Cardiovasc Drugs Ther. </span>2003;<span class="ref-vol">17</span>(5–6):459–465.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15107601" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B8"><span class="mixed-citation">Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM. Risks associated with statin therapy: a systematic overview of randomized clinical trials. <span><span class="ref-journal">Circulation. </span>2006;<span class="ref-vol">114</span>(25):2788–2797. doi: 10.1161/CIRCULATIONAHA.106.624890.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17159064" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.106.624890" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B9"><span class="mixed-citation">Tomlinson SS, Mangione KK. Potential adverse effects of statins on muscle. <span><span class="ref-journal">Phys Ther. </span>2005;<span class="ref-vol">85</span>(5):459–465.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15842193" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B10"><span class="mixed-citation">Sniderman AD. Is there value in liver function test and creatine phosphokinase monitoring with statin use? <span><span class="ref-journal">Am J Cardiol. </span>2004;<span class="ref-vol">94</span>(9A):30F–34F.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15519289" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B11"><span class="mixed-citation">Vaklavas C, Chatzizisis YS, Ziakas A, Zamboulis C, Giannoglou GD. Molecular basis of statin-associated myopathy. <span><span class="ref-journal">Atherosclerosis. </span>2009;<span class="ref-vol">202</span>(1):18–28. doi: 10.1016/j.atherosclerosis.2008.05.021.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18585718" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2Fj.atherosclerosis.2008.05.021" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B12"><span class="mixed-citation">Dirks AJ, Jones KM. Statin-induced apoptosis and skeletal myopathy. <span><span class="ref-journal">Am J Physiol. </span>2006;<span class="ref-vol">291</span>(6):C1208–1212. doi: 10.1152/ajpcell.00226.2006.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16885396" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1152%2Fajpcell.00226.2006" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B13"><span class="mixed-citation">Ucar M, Mjorndal T, Dahlqvist R. HMG-CoA reductase inhibitors and myotoxicity. <span><span class="ref-journal">Drug Saf. </span>2000;<span class="ref-vol">22</span>(6):441–457. doi: 10.2165/00002018-200022060-00003.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/10877038" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.2165%2F00002018-200022060-00003" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B14"><span class="mixed-citation">Omar MA, Wilson JP. FDA adverse event reports on statin-associated rhabdomyolysis. <span><span class="ref-journal">Ann Pharmacother. </span>2002;<span class="ref-vol">36</span>(2):288–295.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11847951" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B15"><span class="mixed-citation">Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients–the PRIMO study. <span><span class="ref-journal">Cardiovasc Drugs Ther. </span>2005;<span class="ref-vol">19</span>(6):403–414. doi: 10.1007/s10557-005-5686-z.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16453090" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1007%2Fs10557-005-5686-z" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B16"><span class="mixed-citation">Grundy SM, Vega GL, Yuan Z, Battisti WP, Brady WE, Palmisano J. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial) <span><span class="ref-journal">Am J Cardiol. </span>2005;<span class="ref-vol">95</span>(4):462–468. doi: 10.1016/j.amjcard.2004.10.012.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15695129" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2Fj.amjcard.2004.10.012" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B17"><span class="mixed-citation">Roth EM, McKenney JM, Kelly MT, Setze CM, Carlson DM, Gold A, Stolzenbach JC, Williams LA, Jones PH. Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study. <span><span class="ref-journal">Am J Cardiovasc Drugs. </span>2010;<span class="ref-vol">10</span>(3):175–186. doi: 10.2165/11533430-000000000-00000.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/20524719" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.2165%2F11533430-000000000-00000" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B18"><span class="mixed-citation">McClure DL, Valuck RJ, Glanz M, Murphy JR, Hokanson JE. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. <span><span class="ref-journal">J Clin Epidemiol. </span>2007;<span class="ref-vol">60</span>(8):812–818. doi: 10.1016/j.jclinepi.2006.11.006.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17606177" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2Fj.jclinepi.2006.11.006" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B19"><span class="mixed-citation">Bruno-Joyce J, Dugas JM, MacCausland OE. Cerivastatin and gemfibrozil-associated rhabdomyolysis. <span><span class="ref-journal">Ann Pharmacother. </span>2001;<span class="ref-vol">35</span>(9):1016–1019.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11573847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B20"><span class="mixed-citation">Phillips PS, Phillips CT, Sullivan MJ, Naviaux RK, Haas RH. Statin myotoxicity is associated with changes in the cardiopulmonary function. <span><span class="ref-journal">Atherosclerosis. </span>2004;<span class="ref-vol">177</span>(1):183–188. doi: 10.1016/j.atherosclerosis.2004.06.014.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15488882" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2Fj.atherosclerosis.2004.06.014" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B21"><span class="mixed-citation">Davidson MH, Armani A, McKenney JM, Jacobson TA. Safety considerations with fibrate therapy. <span><span class="ref-journal">Am J Cardiol. </span>2007;<span class="ref-vol">99</span>(6A):3C–18C.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17368275" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B22"><span class="mixed-citation">Mascitelli L, Pezzetta F. Physical activity in statin-treated patients. <span><span class="ref-journal">Int J Cardiol. </span>2009;<span class="ref-vol">134</span>(1):136–137. doi: 10.1016/j.ijcard.2007.12.048.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18372066" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2Fj.ijcard.2007.12.048" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B23"><span class="mixed-citation">Sinzinger H, O'Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. <span><span class="ref-journal">Br J Clin Pharmacol. </span>2004;<span class="ref-vol">57</span>(4):525–528. doi: 10.1111/j.1365-2125.2003.02044.x.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884475/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15025753" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1111%2Fj.1365-2125.2003.02044.x" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B24"><span class="mixed-citation">Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B. et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) <span><span class="ref-journal">Eur J Cardiovasc Prev Rehabil. </span>2007;<span class="ref-vol">14</span>(2):E1–40. doi: 10.1097/01.hjr.0000277984.31558.c4.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17726406" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1097%2F01.hjr.0000277984.31558.c4" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B25"><span class="mixed-citation">LaRosa JC. Means and ends of statins and low-density lipoprotein cholesterol lowering. <span><span class="ref-journal">J Am Coll Cardiol. </span>2007;<span class="ref-vol">50</span>(5):419–420. doi: 10.1016/j.jacc.2007.04.044.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17662393" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2Fj.jacc.2007.04.044" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B26"><span class="mixed-citation">Domanski MJ. Primary prevention of coronary artery disease. <span><span class="ref-journal">N Engl J Med. </span>2007;<span class="ref-vol">357</span>(15):1543–1545. doi: 10.1056/NEJMe078183.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17928603" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1056%2FNEJMe078183" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B27"><span class="mixed-citation">Mascitelli L, Pezzetta F. Statins for primary prevention of coronary artery disease. <span><span class="ref-journal">Lancet. </span>2007;<span class="ref-vol">369</span>(9567):1078–1079.</span> author reply 1079.  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17398298" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B28"><span class="mixed-citation">Jones PH, Davidson MH. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. <span><span class="ref-journal">Am J Cardiol. </span>2005;<span class="ref-vol">95</span>(1):120–122. doi: 10.1016/j.amjcard.2004.08.076.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15619408" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2Fj.amjcard.2004.08.076" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B29"><span class="mixed-citation">Thompson PD, Zmuda JM, Domalik LJ, Zimet RJ, Staggers J, Guyton JR. Lovastatin increases exercise-induced skeletal muscle injury. <span><span class="ref-journal">Metab Clin Exp. </span>1997;<span class="ref-vol">46</span>(10):1206–1210. doi: 10.1016/S0026-0495(97)90218-3.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9322808" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2FS0026-0495(97)90218-3" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B30"><span class="mixed-citation">Brancaccio P, Maffulli N, Limongelli FM. Creatine kinase monitoring in sport medicine. <span><span class="ref-journal">Br Med Bull. </span>2007;<span class="ref-vol">81-82</span>:209–230.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17569697" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B31"><span class="mixed-citation">Clarkson PM, Kearns AK, Rouzier P, Rubin R, Thompson PD. Serum creatine kinase levels and renal function measures in exertional muscle damage. <span><span class="ref-journal">Med Sci Sports Exerc. </span>2006;<span class="ref-vol">38</span>(4):623–627. doi: 10.1249/01.mss.0000210192.49210.fc.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16679975" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1249%2F01.mss.0000210192.49210.fc" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B32"><span class="mixed-citation">Kearns AK, Bilbie CL, Clarkson PM, White CM, Sewright KA, O'Fallon KS, Gadarla M, Thompson PD. The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. <span><span class="ref-journal">Atherosclerosis. </span>2008;<span class="ref-vol">200</span>(1):121–125. doi: 10.1016/j.atherosclerosis.2007.12.029.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18261731" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1016%2Fj.atherosclerosis.2007.12.029" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B33"><span class="mixed-citation">Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O'Connell TN, Zandi KS, Miller S, Coe JW. Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro. <span><span class="ref-journal">Drug Metab Dispos. </span>2006;<span class="ref-vol">34</span>(1):121–30.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16221753" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B34"><span class="mixed-citation">Corsini A, Bellosta S, Davidson MH. Pharmacokinetic interactions between statins and fibrates. <span><span class="ref-journal">Am J Cardiol. </span>2005;<span class="ref-vol">96</span>(9A):44K–49K.</span> discussion 34K-35K.  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16291014" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="B35"><span class="mixed-citation">Van Peer ASE, Woestenborghs R. Clinical pharmacokinetics of nebivolol. A review. <span><span class="ref-journal">Drug Invest. </span>1991;<span class="ref-vol">3</span>(Suppl. 1):25–30.</span></span></li><li id="B36"><span class="mixed-citation">Frudakis TN, Thomas MJ, Ginjupalli SN, Handelin B, Gabriel R, Gomez HJ. CYP2D6*4 polymorphism is associated with statin-induced muscle effects. <span><span class="ref-journal">Pharmacogenet Genomics. </span>2007;<span class="ref-vol">17</span>(9):695–707. doi: 10.1097/FPC.0b013e328012d0a9.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17700359" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="http://dx.doi.org/10.1097%2FFPC.0b013e328012d0a9" target="pmc_ext" ref="reftype=other&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></li><li id="B37"><span class="mixed-citation">Thompson PD, Clarkson PM, Rosenson RS. An assessment of statin safety by muscle experts. <span><span class="ref-journal">Am J Cardiol. </span>2006;<span class="ref-vol">97</span>(8A):69C–76C.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16581332" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li></ul></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#__abstractid1154731title">Abstract</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#__sec4title">Background</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#__sec5title">Case presentation</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#__sec6title">Conclusions</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#__sec7title">Consent</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#__sec8title">Abbreviations</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#__sec9title">Competing interests</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#__sec10title">Authors’ contributions</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#__sec11title">Acknowledgements</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#__ref-listid1131749title">References</a></li></ul></div></div><!--post-content--><hr class="whole_rhythm no_bottom_margin"><div class="courtesy-note no_margin small">Articles from <span class="acknowledgment-journal-title">BMC Research Notes</span> are provided here courtesy of <strong>BioMed Central</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="try-button"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/?report=reader"><img src="./PMC3571969_files/3838809" alt="PubReader format: click here to try"></a></div><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/epub/">ePub (beta)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/pdf/1756-0500-6-52.pdf">PDF (159K)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" data-citationid="PMC3571969" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3571969%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3571969_files/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3571969%2F&amp;text=Case%20report%20of%20exercise%20and%20statin-fibrate%20combination%20therapy-caused%20myopathy%20in%20a%20patient%20with%20metabolic%20syndrome%3A%20contradictions%20between%20the%20two%20main%20therapeutic%20pathways" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3571969_files/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3571969%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3571969_files/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="23388500" data-aiid="3571969" data-aid="3571969" data-iid="218000" data-domainid="634" data-domain="bmcresnotes" data-accid="PMC3571969" data-md5="aa1d78cda447415860d3775cdeab2227">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-29" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-29" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input type="hidden" name="absid" id="absid" value="3571969"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="http://www.ncbi.nlm.nih.gov/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:&#39;#favUL&#39;,starExists:true,createCollectionUrl:&#39;#&#39;,manageCollectionsUrl:&#39;/myncbi/collections/&#39;"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="http://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input type="submit" class="button_apply" name="addtocollection" value="1"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-31" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-31" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/11485144" ref="reftype=relart&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Statin-fibrate combination therapy.</a><span class="source">[Ann Pharmacother. 2001]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-33" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shek A, Ferrill MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Pharmacother. 2001 Jul-Aug; 35(7-8):908-17. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/20662560" ref="reftype=relart&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Statin-fibrate combination for mixed dyslipidaemia: a limited option?</a><span class="source">[Curr Med Res Opin. 2010]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-35" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Curr Med Res Opin. 2010 Sep; 26(9):2137-40. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/22570173" ref="reftype=relart&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions.</a><span class="source">[Pharmacotherapy. 2012]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-37" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Alford JC, Saseen JJ, Allen RR, Nair KV. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pharmacotherapy. 2012 Jul; 32(7):623-30. Epub 2012 May 8.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/22523582" ref="reftype=relart&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Cardiovascular events in patients received combined fibrate/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data.</a><span class="source">[PLoS One. 2012]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-39" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tenenbaum A, Medvedofsky D, Fisman EZ, Bubyr L, Matetzky S, Tanne D, Klempfner R, Shemesh J, Goldenberg I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">PLoS One. 2012; 7(4):e35298. Epub 2012 Apr 16.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/16276242" ref="reftype=relart&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Statin-induced myositis: a commonly encountered or rare side effect?</a><span class="source">[Curr Opin Lipidol. 2005]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-41" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mukhtar RY, Reckless JP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Curr Opin Lipidol. 2005 Dec; 16(6):640-7. </em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=23388500&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=23388500&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-43" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-43" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=3571969" ref="reftype=MedGen&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-45" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/23388500/" ref="reftype=PubMed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-47" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-49" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-49" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState(&#39;ClearHT&#39;)">Clear</a><a href="javascript:historyDisplayState(&#39;HTOff&#39;)" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState(&#39;HTOn&#39;)" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2a8cf2911de5257e06be">Case report of exercise and statin-fibrate combination therapy-caused myopathy i...</a><div class="ralinkpop offscreen_noflow">Case report of exercise and statin-fibrate combination therapy-caused myopathy in a patient with metabolic syndrome: contradictions between the two main therapeutic pathways<div class="brieflinkpopdesc">BMC Research Notes. 2013; 6()52</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=2" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2a8af0c03b798175f5ee">PMC3571969 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2a2504fcfad591771d3e">Renal Failure and Rhabdomyolysis Associated With Sitagliptin and Simvastatin Use</a><div class="ralinkpop offscreen_noflow">Renal Failure and Rhabdomyolysis Associated With Sitagliptin and Simvastatin Use<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2008 Oct; 25(10)1229</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=4" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2a23f2911de5257df53d">PMC2602841 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2a12f0c03b798175e220">Simvastatin co‐prescribed with protease inhibitors despite dangerous drug intera...</a><div class="ralinkpop offscreen_noflow">Simvastatin co‐prescribed with protease inhibitors despite dangerous drug interactions<div class="brieflinkpopdesc">Sexually Transmitted Infections. 2007 Oct; 83(6)498</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState(&#39;HTOn&#39;)">Turn recording back on</a></p>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p4" name="crb--__p4" rid="__p4" style="position: absolute; visibility: visible; width: 370px; top: 943px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-51"><ul><li class="two_line" reference_id="B1">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16182882/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The metabolic syndrome--a new worldwide definition.</a><span class="one_line_source">[Lancet.  2005]</span><div class="alt-note">
<div class="authors">Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group</div>
<div class="citation">Lancet. 2005 Sep 24-30; 366(9491):1059-62.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p5" name="crb--__p5" rid="__p5" style="position: absolute; visibility: visible; width: 370px; top: 1103px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-52"><ul>
<li class="two_line" reference_id="B2">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16534088/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Health benefits of physical activity: the evidence.</a><span class="one_line_source">[CMAJ.  2006]</span><div class="alt-note">
<div class="authors">Warburton DE, Nicol CW, Bredin SS</div>
<div class="citation">CMAJ. 2006 Mar 14; 174(6):801-9.</div>
</div>
</li>
<li class="two_line" reference_id="B3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12421890/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of the amount and intensity of exercise on plasma lipoproteins.</a><span class="one_line_source">[N Engl J Med.  2002]</span><div class="alt-note">
<div class="authors">Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, Slentz CA</div>
<div class="citation">N Engl J Med. 2002 Nov 7; 347(19):1483-92.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p6" name="crb--__p6" rid="__p6" style="position: absolute; visibility: visible; width: 370px; top: 1198px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-53"><ul>
<li class="two_line" reference_id="B4">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21712404/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).</a><span class="one_line_source">[Eur Heart J.  2011]</span><div class="alt-note">
<div class="authors">European Association for Cardiovascular Prevention &amp; Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees</div>
<div class="citation">Eur Heart J. 2011 Jul; 32(14):1769-818.</div>
</div>
</li>
<li class="two_line" reference_id="B5">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17357251/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Risk of cardiovascular events in patients at optimal values for combined lipid parameters.</a><span class="one_line_source">[Curr Med Res Opin.  2007]</span><div class="alt-note">
<div class="authors">Stanek EJ, Sarawate C, Willey VJ, Charland SL, Cziraky MJ</div>
<div class="citation">Curr Med Res Opin. 2007 Mar; 23(3):553-63.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p7" name="crb--__p7" rid="__p7" style="position: absolute; visibility: visible; width: 370px; top: 1356px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-54"><ul>
<li class="two_line" reference_id="B6">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12106856/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]).</a><span class="one_line_source">[Am J Cardiol.  2002]</span><div class="alt-note">
<div class="authors">de Sauvage Nolting PR, Buirma RJ, Hutten BA, Kastelein JJ, Dutch ExPRESS Investigator Group</div>
<div class="citation">Am J Cardiol. 2002 Jul 15; 90(2):181-4.</div>
</div>
</li>
<li class="two_line" reference_id="B8">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17159064/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Risks associated with statin therapy: a systematic overview of randomized clinical trials.</a><span class="one_line_source">[Circulation.  2006]</span><div class="alt-note">
<div class="authors">Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM</div>
<div class="citation">Circulation. 2006 Dec 19; 114(25):2788-97.</div>
</div>
</li>
<li class="two_line" reference_id="B9">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15842193/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Potential adverse effects of statins on muscle.</a><span class="one_line_source">[Phys Ther.  2005]</span><div class="alt-note">
<div class="authors">Tomlinson SS, Mangione KK</div>
<div class="citation">Phys Ther. 2005 May; 85(5):459-65.</div>
</div>
</li>
<li class="two_line" reference_id="B11" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18585718/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Molecular basis of statin-associated myopathy.</a><span class="one_line_source">[Atherosclerosis.  2009]</span><div class="alt-note">
<div class="authors">Vaklavas C, Chatzizisis YS, Ziakas A, Zamboulis C, Giannoglou GD</div>
<div class="citation">Atherosclerosis. 2009 Jan; 202(1):18-28.</div>
</div>
</li>
<li class="two_line" reference_id="B12" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16885396/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Statin-induced apoptosis and skeletal myopathy.</a><span class="one_line_source">[Am J Physiol Cell Physiol.  2006]</span><div class="alt-note">
<div class="authors">Dirks AJ, Jones KM</div>
<div class="citation">Am J Physiol Cell Physiol. 2006 Dec; 291(6):C1208-12.</div>
</div>
</li>
<li class="two_line" reference_id="B15" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16453090/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.</a><span class="one_line_source">[Cardiovasc Drugs Ther.  2005]</span><div class="alt-note">
<div class="authors">Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B</div>
<div class="citation">Cardiovasc Drugs Ther. 2005 Dec; 19(6):403-14.</div>
</div>
</li>
<li class="two_line" reference_id="B16" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15695129/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).</a><span class="one_line_source">[Am J Cardiol.  2005]</span><div class="alt-note">
<div class="authors">Grundy SM, Vega GL, Yuan Z, Battisti WP, Brady WE, Palmisano J</div>
<div class="citation">Am J Cardiol. 2005 Feb 15; 95(4):462-8.</div>
</div>
</li>
<li class="two_line" reference_id="B17" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20524719/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.</a><span class="one_line_source">[Am J Cardiovasc Drugs.  2010]</span><div class="alt-note">
<div class="authors">Roth EM, McKenney JM, Kelly MT, Setze CM, Carlson DM, Gold A, Stolzenbach JC, Williams LA, Jones PH</div>
<div class="citation">Am J Cardiovasc Drugs. 2010; 10(3):175-86.</div>
</div>
</li>
<li class="two_line" reference_id="B18" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17606177/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.</a><span class="one_line_source">[J Clin Epidemiol.  2007]</span><div class="alt-note">
<div class="authors">McClure DL, Valuck RJ, Glanz M, Murphy JR, Hokanson JE</div>
<div class="citation">J Clin Epidemiol. 2007 Aug; 60(8):812-8.</div>
</div>
</li>
<li class="two_line" reference_id="B20" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15488882/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Statin myotoxicity is associated with changes in the cardiopulmonary function.</a><span class="one_line_source">[Atherosclerosis.  2004]</span><div class="alt-note">
<div class="authors">Phillips PS, Phillips CT, Sullivan MJ, Naviaux RK, Haas RH</div>
<div class="citation">Atherosclerosis. 2004 Nov; 177(1):183-8.</div>
</div>
</li>
<li class="two_line" reference_id="B21" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17368275/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Safety considerations with fibrate therapy.</a><span class="one_line_source">[Am J Cardiol.  2007]</span><div class="alt-note">
<div class="authors">Davidson MH, Armani A, McKenney JM, Jacobson TA</div>
<div class="citation">Am J Cardiol. 2007 Mar 19; 99(6A):3C-18C.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p8" name="crb--__p8" rid="__p8" style="position: absolute; visibility: visible; width: 370px; top: 1535px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-55"><ul>
<li class="two_line" reference_id="B22" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18372066/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Physical activity in statin-treated patients.</a><span class="one_line_source">[Int J Cardiol.  2009]</span><div class="alt-note">
<div class="authors">Mascitelli L, Pezzetta F</div>
<div class="citation">Int J Cardiol. 2009 May 1; 134(1):136-7.</div>
</div>
</li>
<li class="two_line" reference_id="B23" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15025753/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems.</a><span class="one_line_source">[Br J Clin Pharmacol.  2004]</span><div class="alt-note">
<div class="authors">Sinzinger H, O'Grady J</div>
<div class="citation">Br J Clin Pharmacol. 2004 Apr; 57(4):525-8.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/" class="seemore">See links ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p9" name="crb--__p9" rid="__p9" style="position: absolute; visibility: visible; width: 370px; top: 1609px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-56"><ul><li class="two_line" reference_id="B4">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21712404/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).</a><span class="one_line_source">[Eur Heart J.  2011]</span><div class="alt-note">
<div class="authors">European Association for Cardiovascular Prevention &amp; Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees</div>
<div class="citation">Eur Heart J. 2011 Jul; 32(14):1769-818.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p21" name="crb--__p21" rid="__p21" style="position: absolute; visibility: visible; width: 370px; top: 3294px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-57"><ul>
<li class="two_line" reference_id="B24">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17726406/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).</a><span class="one_line_source">[Eur J Cardiovasc Prev Rehabil.  2007]</span><div class="alt-note">
<div class="authors">Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A, European Society of Cardiology (ESC), European Association for Cardiovascular Prevention and Rehabilitation (EACPR), Council on Cardiovascular Nursing, European Association for Study of Diabetes (EASD), International Diabetes Federation Europe (IDF-Europe), European Stroke Initiative (EUSI), International Society of Behavioural Medicine (ISBM), European Society of Hypertension (ESH), European Society of General Practice/Family Medicine (ESGP/FM/WONCA), European Heart Network (EHN)</div>
<div class="citation">Eur J Cardiovasc Prev Rehabil. 2007 Sep; 14 Suppl 2():E1-40.</div>
</div>
</li>
<li class="two_line" reference_id="B4">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21712404/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).</a><span class="one_line_source">[Eur Heart J.  2011]</span><div class="alt-note">
<div class="authors">European Association for Cardiovascular Prevention &amp; Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees</div>
<div class="citation">Eur Heart J. 2011 Jul; 32(14):1769-818.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p22" name="crb--__p22" rid="__p22" style="position: absolute; visibility: visible; width: 370px; top: 3389px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-58"><ul>
<li class="two_line" reference_id="B25">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17662393/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Means and ends of statins and low-density lipoprotein cholesterol lowering.</a><span class="one_line_source">[J Am Coll Cardiol.  2007]</span><div class="alt-note">
<div class="authors">LaRosa JC</div>
<div class="citation">J Am Coll Cardiol. 2007 Jul 31; 50(5):419-20.</div>
</div>
</li>
<li class="two_line" reference_id="B26">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17928603/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Primary prevention of coronary artery disease.</a><span class="one_line_source">[N Engl J Med.  2007]</span><div class="alt-note">
<div class="authors">Domanski MJ</div>
<div class="citation">N Engl J Med. 2007 Oct 11; 357(15):1543-5.</div>
</div>
</li>
<li class="two_line" reference_id="B22" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18372066/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Physical activity in statin-treated patients.</a><span class="one_line_source">[Int J Cardiol.  2009]</span><div class="alt-note">
<div class="authors">Mascitelli L, Pezzetta F</div>
<div class="citation">Int J Cardiol. 2009 May 1; 134(1):136-7.</div>
</div>
</li>
<li class="two_line" reference_id="B27" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17398298/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Statins for primary prevention of coronary artery disease.</a><span class="one_line_source">[Lancet.  2007]</span><div class="alt-note">
<div class="authors">Mascitelli L, Pezzetta F</div>
<div class="citation">Lancet. 2007 Mar 31; 369(9567):1078-9; author reply 1079.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p24" name="crb--__p24" rid="__p24" style="position: absolute; visibility: visible; width: 370px; top: 3579px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-59"><ul><li class="two_line" reference_id="B28">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15619408/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.</a><span class="one_line_source">[Am J Cardiol.  2005]</span><div class="alt-note">
<div class="authors">Jones PH, Davidson MH</div>
<div class="citation">Am J Cardiol. 2005 Jan 1; 95(1):120-2.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p25" name="crb--__p25" rid="__p25" style="position: absolute; visibility: visible; width: 370px; top: 3674px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-60"><ul>
<li class="two_line" reference_id="B29">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9322808/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Lovastatin increases exercise-induced skeletal muscle injury.</a><span class="one_line_source">[Metabolism.  1997]</span><div class="alt-note">
<div class="authors">Thompson PD, Zmuda JM, Domalik LJ, Zimet RJ, Staggers J, Guyton JR</div>
<div class="citation">Metabolism. 1997 Oct; 46(10):1206-10.</div>
</div>
</li>
<li class="two_line" reference_id="B32">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18261731/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg.</a><span class="one_line_source">[Atherosclerosis.  2008]</span><div class="alt-note">
<div class="authors">Kearns AK, Bilbie CL, Clarkson PM, White CM, Sewright KA, O'Fallon KS, Gadarla M, Thompson PD</div>
<div class="citation">Atherosclerosis. 2008 Sep; 200(1):121-5.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p26" name="crb--__p26" rid="__p26" style="position: absolute; visibility: visible; width: 370px; top: 3832px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-61"><ul><li class="two_line" reference_id="B24">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17726406/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).</a><span class="one_line_source">[Eur J Cardiovasc Prev Rehabil.  2007]</span><div class="alt-note">
<div class="authors">Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A, European Society of Cardiology (ESC), European Association for Cardiovascular Prevention and Rehabilitation (EACPR), Council on Cardiovascular Nursing, European Association for Study of Diabetes (EASD), International Diabetes Federation Europe (IDF-Europe), European Stroke Initiative (EUSI), International Society of Behavioural Medicine (ISBM), European Society of Hypertension (ESH), European Society of General Practice/Family Medicine (ESGP/FM/WONCA), European Heart Network (EHN)</div>
<div class="citation">Eur J Cardiovasc Prev Rehabil. 2007 Sep; 14 Suppl 2():E1-40.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p27" name="crb--__p27" rid="__p27" style="position: absolute; visibility: visible; width: 370px; top: 3906px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-62"><ul>
<li class="two_line" reference_id="B33">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16221753/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro.</a><span class="one_line_source">[Drug Metab Dispos.  2006]</span><div class="alt-note">
<div class="authors">Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O'Connell TN, Zandi KS, Miller S, Coe JW</div>
<div class="citation">Drug Metab Dispos. 2006 Jan; 34(1):121-30.</div>
</div>
</li>
<li class="two_line" reference_id="B34">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16291014/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetic interactions between statins and fibrates.</a><span class="one_line_source">[Am J Cardiol.  2005]</span><div class="alt-note">
<div class="authors">Corsini A, Bellosta S, Davidson MH</div>
<div class="citation">Am J Cardiol. 2005 Nov 7; 96(9A):44K-49K; discussion 34K-35K.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p28" name="crb--__p28" rid="__p28" style="position: absolute; visibility: visible; width: 370px; top: 4106px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-63"><ul>
<li class="two_line" reference_id="B4">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21712404/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).</a><span class="one_line_source">[Eur Heart J.  2011]</span><div class="alt-note">
<div class="authors">European Association for Cardiovascular Prevention &amp; Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees</div>
<div class="citation">Eur Heart J. 2011 Jul; 32(14):1769-818.</div>
</div>
</li>
<li class="two_line" reference_id="B36">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17700359/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">CYP2D6*4 polymorphism is associated with statin-induced muscle effects.</a><span class="one_line_source">[Pharmacogenet Genomics.  2007]</span><div class="alt-note">
<div class="authors">Frudakis TN, Thomas MJ, Ginjupalli SN, Handelin B, Gabriel R, Gomez HJ</div>
<div class="citation">Pharmacogenet Genomics. 2007 Sep; 17(9):695-707.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p29" name="crb--__p29" rid="__p29" style="position: absolute; visibility: visible; width: 370px; top: 4264px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-64"><ul>
<li class="two_line" reference_id="B4">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/21712404/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).</a><span class="one_line_source">[Eur Heart J.  2011]</span><div class="alt-note">
<div class="authors">European Association for Cardiovascular Prevention &amp; Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees</div>
<div class="citation">Eur Heart J. 2011 Jul; 32(14):1769-818.</div>
</div>
</li>
<li class="two_line" reference_id="B10">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15519289/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Is there value in liver function test and creatine phosphokinase monitoring with statin use?</a><span class="one_line_source">[Am J Cardiol.  2004]</span><div class="alt-note">
<div class="authors">Sniderman AD</div>
<div class="citation">Am J Cardiol. 2004 Nov 4; 94(9A):30F-34F.</div>
</div>
</li>
<li class="two_line" reference_id="B37">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16581332/" ref="reftype=pubmed&amp;article-id=3571969&amp;issue-id=218000&amp;journal-id=634&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">An assessment of statin safety by muscle experts.</a><span class="one_line_source">[Am J Cardiol.  2006]</span><div class="alt-note">
<div class="authors">Thompson PD, Clarkson PM, Rosenson RS, National Lipid Association Statin Safety Task Force Muscle Safety Expert Panel</div>
<div class="citation">Am J Cardiol. 2006 Apr 17; 97(8A):69C-76C.</div>
</div>
</li>
</ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="./PMC3571969_files/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-B1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The metabolic syndrome--a new worldwide definition.<div class="authors">Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group</div><div class="citation">Lancet. 2005 Sep 24-30; 366(9491):1059-62.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16182882/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B1">Ref list</a>]</p></div><div id="body-link-popper-B2" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Health benefits of physical activity: the evidence.<div class="authors">Warburton DE, Nicol CW, Bredin SS</div><div class="citation">CMAJ. 2006 Mar 14; 174(6):801-9.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16534088/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B2">Ref list</a>]</p></div><div id="body-link-popper-B3" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effects of the amount and intensity of exercise on plasma lipoproteins.<div class="authors">Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, Slentz CA</div><div class="citation">N Engl J Med. 2002 Nov 7; 347(19):1483-92.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12421890/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B3">Ref list</a>]</p></div><div id="body-link-popper-B4" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).<div class="authors">European Association for Cardiovascular Prevention &amp; Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees</div><div class="citation">Eur Heart J. 2011 Jul; 32(14):1769-818.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/21712404/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B4">Ref list</a>]</p></div><div id="body-link-popper-B5" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Risk of cardiovascular events in patients at optimal values for combined lipid parameters.<div class="authors">Stanek EJ, Sarawate C, Willey VJ, Charland SL, Cziraky MJ</div><div class="citation">Curr Med Res Opin. 2007 Mar; 23(3):553-63.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17357251/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B5">Ref list</a>]</p></div><div id="body-link-popper-B6" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]).<div class="authors">de Sauvage Nolting PR, Buirma RJ, Hutten BA, Kastelein JJ, Dutch ExPRESS Investigator Group</div><div class="citation">Am J Cardiol. 2002 Jul 15; 90(2):181-4.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12106856/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B6">Ref list</a>]</p></div><div id="body-link-popper-B8" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Risks associated with statin therapy: a systematic overview of randomized clinical trials.<div class="authors">Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM</div><div class="citation">Circulation. 2006 Dec 19; 114(25):2788-97.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17159064/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B8">Ref list</a>]</p></div><div id="body-link-popper-B9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Potential adverse effects of statins on muscle.<div class="authors">Tomlinson SS, Mangione KK</div><div class="citation">Phys Ther. 2005 May; 85(5):459-65.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15842193/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B9">Ref list</a>]</p></div><div id="body-link-popper-B11" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Molecular basis of statin-associated myopathy.<div class="authors">Vaklavas C, Chatzizisis YS, Ziakas A, Zamboulis C, Giannoglou GD</div><div class="citation">Atherosclerosis. 2009 Jan; 202(1):18-28.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18585718/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B11">Ref list</a>]</p></div><div id="body-link-popper-B12" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Statin-induced apoptosis and skeletal myopathy.<div class="authors">Dirks AJ, Jones KM</div><div class="citation">Am J Physiol Cell Physiol. 2006 Dec; 291(6):C1208-12.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16885396/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B12">Ref list</a>]</p></div><div id="body-link-popper-B15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.<div class="authors">Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B</div><div class="citation">Cardiovasc Drugs Ther. 2005 Dec; 19(6):403-14.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16453090/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B15">Ref list</a>]</p></div><div id="body-link-popper-B16" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).<div class="authors">Grundy SM, Vega GL, Yuan Z, Battisti WP, Brady WE, Palmisano J</div><div class="citation">Am J Cardiol. 2005 Feb 15; 95(4):462-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15695129/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B16">Ref list</a>]</p></div><div id="body-link-popper-B17" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.<div class="authors">Roth EM, McKenney JM, Kelly MT, Setze CM, Carlson DM, Gold A, Stolzenbach JC, Williams LA, Jones PH</div><div class="citation">Am J Cardiovasc Drugs. 2010; 10(3):175-86.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/20524719/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B17">Ref list</a>]</p></div><div id="body-link-popper-B18" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.<div class="authors">McClure DL, Valuck RJ, Glanz M, Murphy JR, Hokanson JE</div><div class="citation">J Clin Epidemiol. 2007 Aug; 60(8):812-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17606177/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B18">Ref list</a>]</p></div><div id="body-link-popper-B20" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Statin myotoxicity is associated with changes in the cardiopulmonary function.<div class="authors">Phillips PS, Phillips CT, Sullivan MJ, Naviaux RK, Haas RH</div><div class="citation">Atherosclerosis. 2004 Nov; 177(1):183-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15488882/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B20">Ref list</a>]</p></div><div id="body-link-popper-B21" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Safety considerations with fibrate therapy.<div class="authors">Davidson MH, Armani A, McKenney JM, Jacobson TA</div><div class="citation">Am J Cardiol. 2007 Mar 19; 99(6A):3C-18C.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17368275/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B21">Ref list</a>]</p></div><div id="body-link-popper-B22" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Physical activity in statin-treated patients.<div class="authors">Mascitelli L, Pezzetta F</div><div class="citation">Int J Cardiol. 2009 May 1; 134(1):136-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18372066/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B22">Ref list</a>]</p></div><div id="body-link-popper-B23" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems.<div class="authors">Sinzinger H, O'Grady J</div><div class="citation">Br J Clin Pharmacol. 2004 Apr; 57(4):525-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15025753/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B23">Ref list</a>]</p></div><div id="body-link-popper-B24" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).<div class="authors">Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A, European Society of Cardiology (ESC), European Association for Cardiovascular Prevention and Rehabilitation (EACPR), Council on Cardiovascular Nursing, European Association for Study of Diabetes (EASD), International Diabetes Federation Europe (IDF-Europe), European Stroke Initiative (EUSI), International Society of Behavioural Medicine (ISBM), European Society of Hypertension (ESH), European Society of General Practice/Family Medicine (ESGP/FM/WONCA), European Heart Network (EHN)</div><div class="citation">Eur J Cardiovasc Prev Rehabil. 2007 Sep; 14 Suppl 2():E1-40.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17726406/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B24">Ref list</a>]</p></div><div id="body-link-popper-B25" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Means and ends of statins and low-density lipoprotein cholesterol lowering.<div class="authors">LaRosa JC</div><div class="citation">J Am Coll Cardiol. 2007 Jul 31; 50(5):419-20.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17662393/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B25">Ref list</a>]</p></div><div id="body-link-popper-B26" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Primary prevention of coronary artery disease.<div class="authors">Domanski MJ</div><div class="citation">N Engl J Med. 2007 Oct 11; 357(15):1543-5.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17928603/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B26">Ref list</a>]</p></div><div id="body-link-popper-B27" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Statins for primary prevention of coronary artery disease.<div class="authors">Mascitelli L, Pezzetta F</div><div class="citation">Lancet. 2007 Mar 31; 369(9567):1078-9; author reply 1079.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17398298/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B27">Ref list</a>]</p></div><div id="body-link-popper-B28" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.<div class="authors">Jones PH, Davidson MH</div><div class="citation">Am J Cardiol. 2005 Jan 1; 95(1):120-2.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15619408/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B28">Ref list</a>]</p></div><div id="body-link-popper-B29" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Lovastatin increases exercise-induced skeletal muscle injury.<div class="authors">Thompson PD, Zmuda JM, Domalik LJ, Zimet RJ, Staggers J, Guyton JR</div><div class="citation">Metabolism. 1997 Oct; 46(10):1206-10.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9322808/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B29">Ref list</a>]</p></div><div id="body-link-popper-B32" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg.<div class="authors">Kearns AK, Bilbie CL, Clarkson PM, White CM, Sewright KA, O'Fallon KS, Gadarla M, Thompson PD</div><div class="citation">Atherosclerosis. 2008 Sep; 200(1):121-5.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18261731/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B32">Ref list</a>]</p></div><div id="body-link-popper-B33" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro.<div class="authors">Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O'Connell TN, Zandi KS, Miller S, Coe JW</div><div class="citation">Drug Metab Dispos. 2006 Jan; 34(1):121-30.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16221753/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B33">Ref list</a>]</p></div><div id="body-link-popper-B34" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacokinetic interactions between statins and fibrates.<div class="authors">Corsini A, Bellosta S, Davidson MH</div><div class="citation">Am J Cardiol. 2005 Nov 7; 96(9A):44K-49K; discussion 34K-35K.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16291014/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B34">Ref list</a>]</p></div><div id="body-link-popper-B35" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="mixed-citation">Van Peer ASE, Woestenborghs R. Clinical pharmacokinetics of nebivolol. A review. <span><span class="ref-journal">Drug Invest. </span>1991;<span class="ref-vol">3</span>(Suppl. 1):25–30.</span></span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B35">Ref list</a>]</div><div id="body-link-popper-B36" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">CYP2D6*4 polymorphism is associated with statin-induced muscle effects.<div class="authors">Frudakis TN, Thomas MJ, Ginjupalli SN, Handelin B, Gabriel R, Gomez HJ</div><div class="citation">Pharmacogenet Genomics. 2007 Sep; 17(9):695-707.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17700359/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B36">Ref list</a>]</p></div><div id="body-link-popper-B10" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Is there value in liver function test and creatine phosphokinase monitoring with statin use?<div class="authors">Sniderman AD</div><div class="citation">Am J Cardiol. 2004 Nov 4; 94(9A):30F-34F.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15519289/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B10">Ref list</a>]</p></div><div id="body-link-popper-B37" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">An assessment of statin safety by muscle experts.<div class="authors">Thompson PD, Clarkson PM, Rosenson RS, National Lipid Association Statin Safety Task Force Muscle Safety Expert Panel</div><div class="citation">Am J Cardiol. 2006 Apr 17; 97(8A):69C-76C.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16581332/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#B37">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <div class="breadcrumbs">You are here: 
            <span id="breadcrumb_text"><a href="http://www.ncbi.nlm.nih.gov/guide/">NCBI</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/guide/literature/">Literature</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central (PMC)</a></span></div>
    <a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target="_blank" href="http://www.ncbi.nlm.nih.gov/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=literature&amp;Snapshot=/projects/PMC/PMCViewer@4.35&amp;Time=2016-06-23T14:29:33-04:00&amp;Host=ptpmc202">Write to the Help Desk</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="./PMC3571969_files/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="http://www.nlm.nih.gov/" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="http://www.nih.gov/" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="http://www.dhhs.gov/" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="http://www.usa.gov/" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            
            <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Copyright</a> | <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html#disclaimer">Disclaimer</a> |
            <a href="http://www.nlm.nih.gov/privacy.html" class="newdomain">Privacy</a> | 
            <a href="http://www.ncbi.nlm.nih.gov/guide/browsers/">Browsers</a> | <a href="http://www.nlm.nih.gov/accessibility.html">Accessibility</a> | <a href="http://www.ncbi.nlm.nih.gov/About/glance/contact_info.html">Contact</a>
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="http://www.ncbi.nlm.nih.gov/">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url"><a href="http://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
        </div>
    </div>
    <script type="text/javascript" src="./PMC3571969_files/InstrumentPageStarterJS.js"> </script>    
    <script type="text/javascript" src="./PMC3571969_files/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div><div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 63.5938px; left: 408.188px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: none;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571969/#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: none;">Turn off</a></div></div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=bmcresnotes&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC3571969/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC7E8376854741_0014SID /projects/PMC/PMCViewer@4.35 ptpmc202 v4.1.r480124 Mon, Sep 28 2015 02:46:19 -->

<script type="text/javascript" src="./PMC3571969_files/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1" style="display: none;"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div><ul class="print-log"><li></li></ul></body></html>